Oriola-KD Corp. Series A | Income Statement

Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,620
1,612
1,626
1,589
1,528
1,552
Cost of Goods Sold (COGS) incl. D&A
1,492
1,465
1,477
1,447
1,389
1,423
Gross Income
128
147
149
142
139
129
SG&A Expense
93
31
100
78
86
89
EBIT
-
116
49
-
53
27
Unusual Expense
9
72
2
7
-
1
Non Operating Income/Expense
4
21
11
13
14
1
Interest Expense
9
8
6
5
4
3
Pretax Income
21
57
56
53
35
24
Income Tax
4
11
12
11
8
6
Equity in Affiliates
-
-
-
-
1
5
Consolidated Net Income
17
47
45
42
26
13
Net Income
17
47
45
42
26
13
Net Income After Extraordinaries
28
305
44
41
26
13
Net Income Available to Common
6
65
45
43
27
13
EPS (Basic)
0.04
1.32
0.25
0.24
0.15
0.07
Basic Shares Outstanding
160
160
178
181
181
181
EPS (Diluted)
0.04
1.33
0.25
0.24
0.14
0.07
Diluted Shares Outstanding
160
160
178
181
181
181
EBITDA
55
138
72
96
79
51
Non-Operating Interest Income
-
-
-
-
-
-

About Oriola-KD

View Profile
Address
Orionintie 5
Espoo UU 02101
Finland
Employees -
Website http://www.oriola-kd.com
Updated 07/08/2019
Oriola Corp. engages in the provision of pharmaceutical, and health and well-being products retail and wholesale. The company provides a wide service offering covering pharmaceutical distribution, branded products, and other tailored services. It operates through the following segments: Consumer, Services, and Healthcare.